FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4306403778> ?p ?o ?g. }

• W4306403778 endingPage "100710" @default.
• W4306403778 startingPage "100710" @default.
• W4306403778 abstract "In children, atopic dermatitis or eczema is the most common inflammatory disease of the skin. According to the International Study of Asthma and Allergies in Childhood (ISAAC) Phase IIIB in Mexico, 5.8% of children and 4.9% of adolescents had eczema symptoms. In 2012, Global Asthma Network (GAN) was established to update the prevalence of eczema and estimate potential factors contributing to its development.To estimate the prevalence and associated factors for atopic eczema symptoms and diagnosis in children and adolescents according to GAN Phase I and compare the results with ISAAC Phase IIIB in Mexico.A cross-sectional, multicenter survey was conducted in 15 Mexican centers during the period of 2015-2017 using the GAN Phase I questionnaires in children (6-7-year-olds) and adolescents (13-14-year-olds). The prevalences obtained from the GAN Phase I study, were compared with ISAAC Phase IIIB results; a Spearman's correlation analysis was conducted between temperature, relative humidity, and altitude and eczema symptoms, and a logistic regression was performed to predict current eczema symptoms by age group.A total of 35 777 children and 41 399 adolescents were included. Since ISAAC Phase IIIB, the prevalence of itchy rash in the past 12 months significantly increased in the children's group [6.6% (95% CI 5.7-7.4) vs 7.8 (95% CI 7.5-8.1), p = 0.000] and adolescents' group [5.8% (95% CI 5.0-6.7) vs 6.7% (95% CI 6.5-7.0), p = 0.000].In the adolescents' group, the prevalence of nocturnal awakenings caused by rash symptoms on more than one night per week had a negative correlation between altitude (Spearman's Rho = -0.558, p value = 0.031), and a positive correlation with the average annual temperature (Spearman's Rho = 0.604, p value = 0.017) and annual relative humidity (Spearman's Rho = 0.742, p value = 0.002). The most significant associations in children were the presence of sneezing or runny or blocked nose in the past 12 months [(OR 3.13, 95% CI 2.60-3.77), p = 0.000], the use of paracetamol in the first year of life ([OR 1.52, 95% CI 1.15-2.01), p = 0.003] and the use of antibiotics in the first year of life [(OR 1.30, 95% CI 1.08-1.55) p = 0.004]. Moreover, altitude at 100-1000 m above sea level was associated with current eczema symptoms in adolescents (p = 0.001).There has been a significant increase in eczema symptoms in both age groups since ISAAC Phase IIIB study. Additionally, eczema symptoms were associated with temperature, relative humidity, asthma, hay fever symptoms, the use of paracetamol and antibiotics." @default.
• W4306403778 created "2022-10-17" @default.
• W4306403778 creator A5020808490 @default.
• W4306403778 creator A5025044314 @default.
• W4306403778 creator A5025732463 @default.
• W4306403778 creator A5025905394 @default.
• W4306403778 creator A5026419747 @default.
• W4306403778 creator A5030207559 @default.
• W4306403778 creator A5039955993 @default.
• W4306403778 creator A5044944933 @default.
• W4306403778 creator A5046086103 @default.
• W4306403778 creator A5051669427 @default.
• W4306403778 creator A5052676254 @default.
• W4306403778 creator A5058358217 @default.
• W4306403778 creator A5059355655 @default.
• W4306403778 creator A5064188106 @default.
• W4306403778 creator A5070144969 @default.
• W4306403778 creator A5080252570 @default.
• W4306403778 creator A5082444243 @default.
• W4306403778 creator A5083248538 @default.
• W4306403778 creator A5086061055 @default.
• W4306403778 creator A5088787760 @default.
• W4306403778 creator A5089148196 @default.
• W4306403778 date "2022-11-01" @default.
• W4306403778 modified "2023-10-18" @default.
• W4306403778 title "Have the prevalence of eczema symptoms increased in the Mexican pediatric population? Prevalence and associated factors according to Global Asthma Network Phase I" @default.
• W4306403778 cites W138708335 @default.
• W4306403778 cites W1479782256 @default.
• W4306403778 cites W1527957830 @default.
• W4306403778 cites W1567692140 @default.
• W4306403778 cites W159343451 @default.
• W4306403778 cites W1822404940 @default.
• W4306403778 cites W1922047650 @default.
• W4306403778 cites W1964235146 @default.
• W4306403778 cites W1971402668 @default.
• W4306403778 cites W1978889258 @default.
• W4306403778 cites W1981500886 @default.
• W4306403778 cites W1983445034 @default.
• W4306403778 cites W1984525156 @default.
• W4306403778 cites W1990544757 @default.
• W4306403778 cites W1999411814 @default.
• W4306403778 cites W2017385793 @default.
• W4306403778 cites W2017850486 @default.
• W4306403778 cites W2020594252 @default.
• W4306403778 cites W2027411190 @default.
• W4306403778 cites W2028246447 @default.
• W4306403778 cites W2035265893 @default.
• W4306403778 cites W2057026936 @default.
• W4306403778 cites W2063516016 @default.
• W4306403778 cites W2065926781 @default.
• W4306403778 cites W2072967624 @default.
• W4306403778 cites W2090659670 @default.
• W4306403778 cites W2098938763 @default.
• W4306403778 cites W2110194574 @default.
• W4306403778 cites W2113939182 @default.
• W4306403778 cites W2120793327 @default.
• W4306403778 cites W2123774190 @default.
• W4306403778 cites W2130345799 @default.
• W4306403778 cites W2134261811 @default.
• W4306403778 cites W2143317798 @default.
• W4306403778 cites W2168197703 @default.
• W4306403778 cites W2171343997 @default.
• W4306403778 cites W2243398804 @default.
• W4306403778 cites W2415577141 @default.
• W4306403778 cites W2472785485 @default.
• W4306403778 cites W2513454888 @default.
• W4306403778 cites W2561808084 @default.
• W4306403778 cites W2615746742 @default.
• W4306403778 cites W2617727916 @default.
• W4306403778 cites W2753928720 @default.
• W4306403778 cites W2800199745 @default.
• W4306403778 cites W2820763047 @default.
• W4306403778 cites W2888649735 @default.
• W4306403778 cites W2913194828 @default.
• W4306403778 cites W2918395485 @default.
• W4306403778 cites W2970735527 @default.
• W4306403778 cites W2983911779 @default.
• W4306403778 cites W2994132278 @default.
• W4306403778 cites W3009173902 @default.
• W4306403778 cites W3098203414 @default.
• W4306403778 cites W3128783432 @default.
• W4306403778 cites W3164542342 @default.
• W4306403778 cites W3191548463 @default.
• W4306403778 cites W4206005281 @default.
• W4306403778 cites W4211026773 @default.
• W4306403778 cites W4211028210 @default.
• W4306403778 cites W4230355606 @default.
• W4306403778 cites W956837242 @default.
• W4306403778 doi "https://doi.org/10.1016/j.waojou.2022.100710" @default.
• W4306403778 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36267354" @default.
• W4306403778 hasPublicationYear "2022" @default.
• W4306403778 type Work @default.
• W4306403778 citedByCount "3" @default.
• W4306403778 countsByYear W43064037782023 @default.
• W4306403778 crossrefType "journal-article" @default.
• W4306403778 hasAuthorship W4306403778A5020808490 @default.
• W4306403778 hasAuthorship W4306403778A5025044314 @default.
• W4306403778 hasAuthorship W4306403778A5025732463 @default.

• next